A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain

Clinical trial NCT00929188 · COMPLETED

Trial details

NCT number: NCT00929188
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pain, Burning Pain, Crushing Pain, Migratory Pain, Radiating Pain, Splitting

Start date: 2009-10-01
Primary completion: 2015-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.